Immune Biomarkers May Better Classify Patients, Direct Therapy, Study Says
Biomarkers of brain inflammation could provide a useful means for classifying Parkinson’s and Alzheimer’s patients and defining the…
Articles by Ana Pena, PhD
First Patient Dosed in Neuraly’s NLY01 Trial Testing Safety, Efficacy
The first patient has been dosed in a Phase 2 study testing NLY01, an investigational compound with a…
Dizziness May Be Non-Motor Symptom of Early Parkinson’s, Study Finds
Dizziness — including sensations of fainting, imbalance, and vertigo — is common among Parkinson’s patients and may be a potential…
Awakening Dormant Neurons Could Provide Disease-modifying Parkinson’s Treatment, Early Study Suggests
Together with dying nerve cells, dormant neurons also may be at the root cause of Parkinson’s disease, according…
Saliva Test May Help Diagnose Parkinson’s, Assess Disease Severity, Early Study Finds
A saliva test may help diagnose Parkinson’s and assess disease severity, according to a recent study. Biomarkers…
Personalized Brain Maps May Help Improve Deep Brain Stimulation for Parkinson’s, Other Conditions
Not everyone’s brain connections map at exactly the same location, which may explain why deep brain stimulation (DBS) therapy, used…
Brain MRIs Can Be Used to Detect Early Signs of Parkinson’s Cognitive Impairment, Study Suggests
Brain magnetic resonance imaging (MRI) scans could be used to detect early and subtle markers of cognitive impairment…
Researchers Identify Gene Networks Underlying Parkinson’s Development
Researchers have found new gene networks associated with the development of Parkinson’s disease, which may help them understand the…
Earlier Onset, Cognitive Impairment and Higher Medication Use Linked to Increased Parkinson’s-related Mortality
Earlier onset of disease, early impairment of memory and thinking, and higher daily use of antiparkinson medication, are associated with…
Researchers Find New Enzyme That Might Aid in ‘Putting the Brakes’ on Parkinson’s Disease
Researchers have discovered a new enzyme that might aid in “putting the brakes” on Parkinson’s by inhibiting the LRRK2…